Summary: This article discusses promising gene therapies for the treatment of patients with polyglutamine spinocerebellar ataxias (loss of movement control; PolyQ SCAs).
Summary: This study investigated the clinical outcome of treating low testosterone levels with testosterone replacement therapy in male patients with spinocerebellar ataxia type 2.
Summary: This study reported clinical and ancillary findings in a kindred with spinocerebellar ataxia 38 (gait abnormality; SCA38) treated with oral 26-week dietary DHA supplementation, 650 mg/day.
Summary: This study evaluated the safety and effectiveness of bilateral medial rectus (BMR) recession (weakening of eye muscle during strabismus surgery) for the treatment of patients with spinocerebellar ataxia (SCA).
Summary: This study tested the safety and efficacy of using a neurorehabilitation intervention to treat patients with prodromal spinocerebellar ataxia type 2.
Summary: This study tested the safety and efficacy of using intrathecal baclofen to treat patients with inherited ataxia spasticity and painful spasms.
Summary: The purpose of the study was to evaluate the effects of physical neurorehabilitation on the clinical and biochemical features of patients with spinocerebellar ataxia type 7.